LED Medical Diagnostics Names Ralph Green President and CEO

LED Medical Diagnostics Names Ralph Green President and CEO
Dental Industry Veteran Brings Unique Blend of Executive and Clinical Expertise

WHITE ROCK, British Columbia—October 15, 2008—LED Medical Diagnostics Inc. today announced that Ralph Green, D.D.S., has been named President and CEO.

The company also made two other announcements:

· Founder Peter Whitehead is re-assuming the position of Chairman of the company’s Board of Directors. He replaces Steven Semmelmayer, who remains a Director.
· Rick Pauls has joined the company’s Board of Directors. Mr. Pauls is Managing Director at CentreStone Ventures in Winnipeg, Manitoba.

LED Medical Diagnostics is the parent of LED Dental, manufacturer of the VELscope Oral Cancer Screening System. The VELscope system, recently named one of 2008’s Top 100 Products by Dentistry Today, is the only device on the market that is indicated for use by the FDA to help dental practitioners discover cancerous and precancerous lesions that may not be apparent to the naked eye.

“This is an exciting time in the young history of our company,” said Mr. Whitehead. “While we are proud of what we have been able to achieve in only a few years, we have determined that achieving our full potential will require the vision and leadership of someone who has successfully run both start-up and established companies in the dental industry. We are very fortunate to have found that person in Ralph Green, who brings a rare blend of both managerial and clinical expertise.”

“As a clinician, there is no doubt in my mind that VELscope’s tissue fluorescence visualization technology offers dental practices their best opportunity for discovering early stage oral cancer and even precancer,” said Dr. Green. “And as a businessman, I am impressed with the fact that VELscope exam revenues can pay back the device’s purchase cost within months and generate significant profits for the practice for years to come. My number one priority is to make certain that we get the word out so that dentists fully appreciate the VELscope’s ability to enhance the health both of their patients and of their bottom line.”

Dr. Green has held a number of key positions in the dental industry, amassing considerable corporate, entrepreneurial, academic, clinical and volunteer experience in the process. He was the founder of Nobel USA, which is now the largest dental implant company in the world. Dr. Green later founded a dental implant company that he sold in 18 months to a publicly-traded company. He subsequently served as President of the Zila Pharmaceuticals division of Zila, Inc. His other corporate positions have included President of Ralph Green DDS PC, and Vice President of Clinical Affairs for Reachout Healthcare America, which provides healthcare services to underserved communities in twenty-one states and to the brave men and women serving in our country’s armed forces. Dr. Green began his career in private dental practice, later serving as a faculty member of Tufts University Dental School and the Forsyth School of Dental Hygiene. He has served as the President-elect of the Dental Manufacturers of America and on the Board of Oral Health America, and is a founder of the Arizona School for Oral Health and a trustee of the Forsyth Institute. He is also a member of the American Dental Association, the American Association for Dental Research and the International Association for Dental Research. He has conducted extensive research in the areas of bone growth, implants, tissue engineering and oncology, is the holder of numerous patents, and is considered an expert in stewarding dental devices through the FDA registration process. He received his Doctorate in Dental Surgery from the University of Iowa and his MBA from Boston University.

About LED Medical Diagnostics

LED Medical Diagnostics Inc., founded in 2003 and headquartered in White Rock, British Columbia, Canada, is the parent company of LED Dental Inc., manufacturer of the VELscope Oral Cancer Screening System. For more information, call 1-888-541-4614, or visit www.VELscope.com.

LED Medical Diagnostics Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by the company) contains statements that are forward-looking, such as statements relating to anticipated future revenues of the company and success of current product offerings. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward-looking statements made by or on behalf of the company. For a description of additional risks and uncertainties, please refer to the company’s filings with the Securities and Exchange Commission.